It is currently Tue Feb 09, 2016 12:47 pm

News News of Tysabri (Antegren or Natalizumab)

Site map of Tysabri (Antegren or Natalizumab) » Forum : Tysabri (Antegren or Natalizumab)

A board to discuss the newly-released drug Tysabri, (formerly known as Antegren) as a treatment for Multiple Sclerosis

Biogen sells factory

In today's Times (UK) the following appeared in the business pages:

'Biogen Idec, the US biotech company, sold a new factory to Genentech, a US rival for $408 million (£223 million). It was built to make Tysabri, the multiple sclerosis drug withdrawn amid brain disease fears'.

Perhaps this indicates that Biogen is not confident of the drug returning in the near future.

Read more : Biogen sells factory | Views : 1788 | Replies : 2

FDA - New Drug Protocol

There's a good story on NPR's Morning Edition today about the FDA's procedure for follow up on newly approved drugs. There is a scientific review commitee (convening today) created to evaluate how this method can be improved.

Currently the FDA has 2 methods of follow up in place for fast track drugs:
1) Spontaneous Adverse Reaction Reporting System - almost tota lly ineffective because busy physicians, pharmacists, etc. do not take the initiative to report ...
Read more : FDA - New Drug Protocol | Views : 1556 | Replies : 1

Shingles after Tysabri

I developed shingles a couple months after having Tysabri treatments. I understand that a person is more suseptible to developing shingles if they have had drugs that suppress the immune system. I want to know if anyone else has developed shingles after Tysabri or if there might be a link at all. If so I'm wondering if it would be such a good idea to resume Tysabri treatment if it becomes available again.


Read more : Shingles after Tysabri | Views : 3921 | Replies : 4

Elan AGM Webcast Transcript 2005

Élan AGM Webcast Transcript - May 26, 2005

Opening Remarks:

(Kyran McLachlan): Annual General Meeting of Élan Corporation PLC. And the time is just after 10 o’clock and we can start our proceedings. The articles of the company require that 3 or more persons being holders of at least 1/3 of the issued ordinary shares of the company are present in person or are represented by proxy before a meeting of shareholders can take place. ...
Read more : Elan AGM Webcast Transcript 2005 | Views : 1882 | Replies : 1

Press would like to talk to Tysabri users

Jeff Krasner from the Boston Globe is a reporter who has been covering the Tysabri story. He would like to get the patient side of the story and has asked if I know anyone who was on the drug who would be willing to talk to him. I thought I'd check with the folks at ThisIsMS.

He wrote a letter to patients that you can find here:

He ...
Read more : Press would like to talk to Tysabri users | Views : 1599 | Replies : 0


Data Presented at American Academy of Neurology Meeting

Cambridge, MA and Dublin, Ireland - April 12, 2005 -Two-year data from the AFFIRM Phase III monotherapy trial presented today for the first time, showed that treatment with TYSBARI® (natalizumab) led to a significant reduction in disability progression, the rate of clinical relapses and brain lesions in patients with ...
Read more : TYSABRI® TWO-YEAR MONOTHERAPY DATA | Views : 3580 | Replies : 12

Progressive Multifocal Leukoencephalopathy(PML) info

Progressive Multifocal Leukoencephalopathy(PML) info

New research article for May 2005 release describes full recovery of PML after removal of immune suppression. I think immune monitoring can remove PML cases from occurring.

Am J Transplant. 2005 May,5

Successful outcome of progressive multifocal leukoencephalopathy in a renal transplant patient.

Crowder CD, Gyure KA, Drachenberg CB, Werner J, Morales RE, Hirsch HH, Ramos E.

Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland, USA.

We ...
Read more : Progressive Multifocal Leukoencephalopathy(PML) info | Views : 3935 | Replies : 12

Calling all ex-tysabri patients...

I would be curious to know from the MSr's that took Tysabri and saw some benefit from it, how the lack of it has affected you?
Read more : Calling all ex-tysabri patients... | Views : 2367 | Replies : 3

Elan at SG Cowen Annual Healthcare Conference

Elan at SG Cowen Annual Healthcare Conference

March 16, 2005


We will get started here. This next session is Elan and I am pretty sure you all know what they are up to. But joining us today, and we were happy his, is CEO Kelly Martin and Head of R&D Lars Ekman, and the way this is going to work is Kelly is going to spend probably about half the session ...
Read more : Elan at SG Cowen Annual Healthcare Conference | Views : 2550 | Replies : 7


Login  •  Register


Total posts 230326 • Total topics 24459 • Total members 15700

Contact us | Terms of Service